CURE

SPRING / 2009

Features

Trying Something NewThe gold standard in treating non-Hodgkin lymphoma gets new backup. 

BY NICOLE LEBRASSEUR, PHD AND HEATHER L. VAN EPPS, PHD

The Medicare PrognosisChanges to Medicare find patients and providers playing by new rules. 

BY TERESA MCUSIC

The Final Journey

BY KATHY LATOUR

Contents

First Line

People, News & Events

EDITED BY STAFF

Diagnosis Cancer

The Good Cancer?Thyroid cancer's high survival rate masks the sometimes tricky tumor. 

BY CHARLOTTE HUFF

Finding Hope

Mind GamesAddressing and correcting cognitive problems in older cancer patients. 

BY LAURA BEIL

Moving On

Warrior SurvivorsBreast cancer survivors find healing in the challenges of the road. 

BY KATHY LATOUR

Healing Well

Battling Cancer AgainWhy treatment of one cancer could lead to the diagnosis of a new cancer. 

BY TERESA MCUSIC

Caregivers' Corner

Stressed OutOverwhelmed spouse caregivers take control of stress.

BY LACEY MEYER

In Every Issue

Editor's Page

Message From the EditorCreating a "wish list" for health care reform. 

BY DEBU TRIPATHY, MD

Letters from Our Readers

Letters from Our ReadersReaders respond to past articles. 

Side Note

New BloodFDA decision changes the routine for treating cancer-related anemia. 

BY SUSAN KREIMER

Special Report

Should Breast Cancer Patients Make the Switch?Is it best to start with tamoxifen and then switch to an aromatase inhibitor (AI), or should the AI come first? 

BY BEVERLY A. CALEY

Food for Thought

Soy StorySorting out the effects of soy products on breast cancer cells. 

BY LENA HUANG

Readers' Forum

When Do I Tell Her?The struggle of when to reveal my health history to a romantic interest. 

BY JASAN ZIMMERMAN

Drugs in the News

Lymphoma, Myeloma & Prostate CancerFDA approves Mozobil for non-Hodgkin lymphoma and myeloma, and Degarelix for advanced prostate cancer. 

BY ELIZABETH WHITTINGTON

Speaking Out

Choosing the Right PlanHow to navigate Medicare Part D to get the coverage you need. 

BY CHRISTY SCHMIDT

Web Exclusives

Treatment UpdatesTreatment updates from the 2009 ASCO Gastrointestinal Cancers Symposium.

BY SUSAN PECK, PHD

The Ins and Outs of PortsA port can make intravenous chemotherapy easier on patients. 

BY CURTIS PESMEN

CONTENTS

Web Exclusive: Cognitive Changes


PUBLISHED MARCH 13, 2009

RELATED ARTICLES

For more information on cancer-related cognitive changes, including dementia, delirium, and chemobrain, view “Cognitive Changes” at www.livestrong.org.

^ TOP OF PAGE